Video

A PSA for Myeloproliferative Neoplasms

Author(s):

After realizing how little awareness there was about MPNs, one advocate looked to his TV background to help.

Richard French describes how he knew that his public service announcement (PSA) about myeloproliferative neoplasms (MPNs) was working — and what more work still needs to be done.

After French’s daughter was diagnosed with thrombocythemia, he grew frustrated at the lack of awareness about MPNs. So, he put his television background to good use and worked on a PSA that would air in markets across the nation. And while the PSA led to more money raised for the disease, French mentioned that he still hopes to grow the donor base of people contributing to the cause.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Related Content